These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 39110401)

  • 1. RBM25 depletion suppresses the growth of colon cancer cells through regulating alternative splicing of MNK2.
    Zhi L; Chen C; Zhang G; Huang T; He W; Zhang J; Chen D; Liu J; Zhao J; Qi Y; Wang G; Zhang W; Wang Y
    Sci China Life Sci; 2024 Oct; 67(10):2186-2197. PubMed ID: 39110401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SRPK1/2 and PP1α exert opposite functions by modulating SRSF1-guided MKNK2 alternative splicing in colon adenocarcinoma.
    Liu H; Gong Z; Li K; Zhang Q; Xu Z; Xu Y
    J Exp Clin Cancer Res; 2021 Feb; 40(1):75. PubMed ID: 33602301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RBM25 is a global splicing factor promoting inclusion of alternatively spliced exons and is itself regulated by lysine mono-methylation.
    Carlson SM; Soulette CM; Yang Z; Elias JE; Brooks AN; Gozani O
    J Biol Chem; 2017 Aug; 292(32):13381-13390. PubMed ID: 28655759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of MKNK2 alternative splicing by splice-switching oligonucleotides as a novel approach for glioblastoma treatment.
    Mogilevsky M; Shimshon O; Kumar S; Mogilevsky A; Keshet E; Yavin E; Heyd F; Karni R
    Nucleic Acids Res; 2018 Nov; 46(21):11396-11404. PubMed ID: 30329087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel splicing factor RBM25 modulates Bcl-x pre-mRNA 5' splice site selection.
    Zhou A; Ou AC; Cho A; Benz EJ; Huang SC
    Mol Cell Biol; 2008 Oct; 28(19):5924-36. PubMed ID: 18663000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic alternative splicing regulatory network of RBM25 in hepatocellular carcinoma.
    Zhang YF; Wang YX; Zhang N; Lin ZH; Wang LR; Feng Y; Pan Q; Wang L
    Bioengineered; 2021 Dec; 12(1):1202-1211. PubMed ID: 33830865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mnk2 alternative splicing modulates the p38-MAPK pathway and impacts Ras-induced transformation.
    Maimon A; Mogilevsky M; Shilo A; Golan-Gerstl R; Obiedat A; Ben-Hur V; Lebenthal-Loinger I; Stein I; Reich R; Beenstock J; Zehorai E; Andersen CL; Thorsen K; Ørntoft TF; Davis RJ; Davidson B; Mu D; Karni R
    Cell Rep; 2014 Apr; 7(2):501-513. PubMed ID: 24726367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The N and C termini of the splice variants of the human mitogen-activated protein kinase-interacting kinase Mnk2 determine activity and localization.
    Scheper GC; Parra JL; Wilson M; Van Kollenburg B; Vertegaal AC; Han ZG; Proud CG
    Mol Cell Biol; 2003 Aug; 23(16):5692-705. PubMed ID: 12897141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gemcitabine triggers a pro-survival response in pancreatic cancer cells through activation of the MNK2/eIF4E pathway.
    Adesso L; Calabretta S; Barbagallo F; Capurso G; Pilozzi E; Geremia R; Delle Fave G; Sette C
    Oncogene; 2013 Jun; 32(23):2848-57. PubMed ID: 22797067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The splicing factor SRSF6 is amplified and is an oncoprotein in lung and colon cancers.
    Cohen-Eliav M; Golan-Gerstl R; Siegfried Z; Andersen CL; Thorsen K; Ørntoft TF; Mu D; Karni R
    J Pathol; 2013 Mar; 229(4):630-9. PubMed ID: 23132731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive analysis of RNA-binding protein SRSF2-dependent alternative splicing signature in malignant proliferation of colorectal carcinoma.
    Liu W; Li D; Lu T; Zhang H; Chen Z; Ruan Q; Zheng Z; Chen L; Guo J
    J Biol Chem; 2023 Feb; 299(2):102876. PubMed ID: 36623729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BCLAF1 and its splicing regulator SRSF10 regulate the tumorigenic potential of colon cancer cells.
    Zhou X; Li X; Cheng Y; Wu W; Xie Z; Xi Q; Han J; Wu G; Fang J; Feng Y
    Nat Commun; 2014 Aug; 5():4581. PubMed ID: 25091051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RBM25 binds to and regulates alternative splicing levels of
    Tian X; Zhou G; Li H; Zhang X; Zhao L; Zhang K; Wang L; Liu M; Liu C; Yang P
    PeerJ; 2023; 11():e16312. PubMed ID: 37953772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic profiling of alternative splicing events and splicing factors in left- and right-sided colon cancer.
    Huang X; Liu J; Mo X; Liu H; Wei C; Huang L; Chen J; Tian C; Meng Y; Wu G; Xie W; P C FJ; Liu Z; Tang W
    Aging (Albany NY); 2019 Oct; 11(19):8270-8293. PubMed ID: 31586988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alternative splicing of SLC39A14 in colorectal cancer is regulated by the Wnt pathway.
    Thorsen K; Mansilla F; Schepeler T; Øster B; Rasmussen MH; Dyrskjøt L; Karni R; Akerman M; Krainer AR; Laurberg S; Andersen CL; Ørntoft TF
    Mol Cell Proteomics; 2011 Jan; 10(1):M110.002998. PubMed ID: 20938052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficient, specific, and combinatorial control of endogenous exon splicing with dCasRx-RBM25.
    Li JD; Taipale M; Blencowe BJ
    Mol Cell; 2024 Jul; 84(13):2573-2589.e5. PubMed ID: 38917795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imbalanced splicing in MAPK signaling sustains Ras-induced transformation.
    Müller D; Martineau Y; Bousquet C; Pyronnet S
    Clin Res Hepatol Gastroenterol; 2015 Apr; 39(2):155-6. PubMed ID: 25468550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphorylation of SRSF1 by SRPK1 regulates alternative splicing of tumor-related Rac1b in colorectal cells.
    Gonçalves V; Henriques AF; Pereira JF; Neves Costa A; Moyer MP; Moita LF; Gama-Carvalho M; Matos P; Jordan P
    RNA; 2014 Apr; 20(4):474-82. PubMed ID: 24550521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Genetic Screen for Pre-mRNA Splicing Mutants of
    Kanno T; Lin WD; Fu JL; Chang CL; Matzke AJM; Matzke M
    Genetics; 2017 Dec; 207(4):1347-1359. PubMed ID: 28971960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The splicing factor RBM4 controls apoptosis, proliferation, and migration to suppress tumor progression.
    Wang Y; Chen D; Qian H; Tsai YS; Shao S; Liu Q; Dominguez D; Wang Z
    Cancer Cell; 2014 Sep; 26(3):374-389. PubMed ID: 25203323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.